Valdoxan® (Agomelatine): new Evidence Shows Significant Efficacy in Treatment of Anxiety in Depressed Patients

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | PRN

print